Colorectal Cancer Clinical Trials

A listing of Colorectal Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 115 clinical trials
featured
A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients With Advanced Solid Tumors With KRAS G12C Mutation

Evaluates the safety, tolerability, pharmacokinetics, metabolites, pharmacodynamics, and clinical activity of MRTX849 in patients with advanced solid tumors with a KRAS G12C mutation. MRTX849 is an orally-available small molecule inhibitor of KRAS G12C.  

  • 405 views
  • 23 Nov, 2020
  • 61 locations
featured
Advanced Colorectal or Lung Cancer Screening

Advanced Colorectal or Lung Cancer Screening

  • 158 views
  • 23 Nov, 2020
  • 1 location
featured
A Phase II-R and A Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (PhIII) as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma

A Phase II-R and A Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (PhIII) as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma

adenocarcinoma
erlotinib
  • 178 views
  • 24 Nov, 2020
  • 1 location
featured
CASCADE FH Registry: Cascade Screening for Awareness and Detection of Familial Hypercholesterolemia

CASCADE FH Registry: Cascade Screening for Awareness and Detection of Familial Hypercholesterolemia

  • 434 views
  • 23 Nov, 2020
  • 1 location
DRAGON 1- Training Accreditation Implementation and Safety Evaluation of Combined PVE/HVE

Brief Summary: Some colorectal liver metastases can only be resected after inducing liver regeneration by portal vein embolization (PVE) to increase size function of the future liver remnant (FLR). While PVE is standard, embolization of portal vein and hepatic veins (PVE/HVE) on one side of the liver may faster and …

  • 0 views
  • 21 Nov, 2020
  • 20 locations
Efficacy and Safety of Olaparib Olaparib + Bevacizumab Compared to Bevacizumab + 5-Fluorouracil (FU)

colorectal cancer (CRC) who have not progressed following first-line induction of FOLFOX with bevacizumab. Hypothesis 1 - Olaparib + Bevacizumab is superior to 5-FU + Bevacizumab with respect to progression

bevacizumab
folfox regimen
solid tumour
fluorouracil
systemic chemotherapy
  • 10 views
  • 02 Dec, 2020
  • 59 locations
Optimising Colorectal Cancer Screening Participation

will be nested into the Danish colorectal cancer screening programme in the Central Denmark Region including men and women aged 50-74 years. Participants will consecutively be randomized into four arms

screening for colorectal cancer
cancer screening
  • 0 views
  • 20 Nov, 2020
  • 1 location
Effectiveness and Implementation of mPATH-CRC

Study Investigators are conducting this study to learn how to best implement a new iPad program in clinical practice.

blood test
fecal immunochemical test
KIT
  • 2 views
  • 26 Nov, 2020
  • 1 location
Physical Activity in Patients With Metastatic Colorectal Cancer Who Receive Palliative First-line Chemotherapy

outcomes (ESAS-r) in patients with metastatic colorectal cancer.

carcinoma
ct scan
primary tumor
metastasis
measurable disease
  • 154 views
  • 24 Nov, 2020
  • 38 locations
Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer

This phase III trial studies how well vitamin D3 given with standard chemotherapy and bevacizumab works in treating patients with colorectal cancer that has spread to other parts of the body

metastatic colorectal adenocarcinoma
bevacizumab
open biopsy
fluorouracil
irinotecan
  • 65 views
  • 20 Nov, 2020
  • 888 locations